Insmed Incorporated
NASDAQ: INSM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- William H. Lewis
- Employees
- 1,271
- Headquarters
- Bridgewater, United States
- IPO year
- 2000
- Market cap
- $20.8B
- Website
- https://www.insmed.com
Loading INSM…
Loading profile data…Frequently asked questions about INSM
What does Insmed Incorporated (INSM) do?
Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a...
Where does INSM trade?
Insmed Incorporated (INSM) trades on the NASDAQ Global Select.
What sector is INSM in?
Insmed Incorporated (INSM) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Insmed Incorporated?
William H. Lewis is the chief executive officer of Insmed Incorporated (INSM).
Where is Insmed Incorporated headquartered?
Insmed Incorporated is headquartered in United States.
Does INSM pay a dividend?
Insmed Incorporated (INSM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INSM go public?
Insmed Incorporated (INSM) completed its initial public offering in 2000.